Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway.
Cell Reports Volume 40, Issue 5, 2 August 2022, 111158.
Haiyang Sun, Ce Tang, Soo-HyunChung, Xiao-Qi Ye, Yulia Makusheva, Wei Han, Masato Kubo, Shigeyuki Shichino, Satoshi Ueha, Koji Matsushima, Kazuho Ikeo, Masahide Asano, Yoichiro Iwakura.
https://doi.org/10.1016/j.celrep.2022.111158
東京理科大学HP プレスリリース
https://www.tus.ac.jp/today/archive/20220803_2356.html